DNA X, Inc. SONM
3.92
(0.03)
(0.76%)
as of 25 Sep
- Market cap
- $5.9M
- P/E
- 0.0×
Follow SONM
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
2.25 | 2.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
1.21 | 1.21 | 0.58 | 0.52 | 0.16 | 0.18 | 0.35 | 0.26 | — |
P/FCF ratio |
79.60 | 79.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(38.45) | (38.45) | (14.26) | (3.40) | (0.50) | (5.59) | (92.30) | (3.30) | — |
P/B ratio |
283.06 | 283.06 | 2.64 | 1.18 | 0.47 | 0.62 | 1.45 | 0.00 | — |
Price to Tangible BV |
283.06 | 283.06 | 2.64 | 1.18 | 0.54 | 0.94 | 2.47 | 0.00 | — |
EV/Sales |
1.23 | 1.23 | 0.57 | 0.18 | (0.04) | (0.01) | 0.25 | 0.17 | — |
EV/EBITDA |
23.55 | 23.55 | 0.00 | 0.00 | 0.06 | 0.05 | 8.49 | 0.22 | — |
EV/Operating CF |
44.26 | 44.26 | (1.97) | (1.11) | 0.06 | 0.05 | (5.70) | (1.14) | — |
EV/FCF |
81.21 | 81.21 | (1.90) | (1.11) | 0.06 | 0.05 | (5.65) | (1.11) | — |
Quick Ratio |
0.49 | 0.66 | 0.77 | 1.31 | 1.16 | 1.18 | 1.11 | 0.39 | 0.03 |
Current Ratio |
0.98 | 1.33 | 1.71 | 2.23 | 1.70 | 1.36 | 1.36 | 0.74 | 0.60 |
Net Debt/EBITDA |
(1.67) | 0.06 | 0.06 | 0.82 | 0.31 | 1.10 | (3.46) | (11.69) | 1.18 |
Debt/Assets |
0.00% | 20.06% | 18.36% | 0.72% | 0.52% | 0.27% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(1.12) | 2.63 | 0.40 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.21 | 4.03 | 1.89 | 1.21 | 1.19 | 1.47 | 1.71 | 1.22 | 0.00 |
Operating CF/Net income |
0.58 | (0.43) | 1.30 | 0.35 | 1.00 | 0.88 | 45.02 | 0.25 | 1.14 |
Capex/Depreciation |
0.00 | (1.38) | (0.38) | 0.00 | (0.02) | 0.00 | (0.02) | (0.06) | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 36.22% | 20.94% | (168.55%) | (110.99%) | (164.23%) | (72.85%) | (0.42%) | (403.74%) | 302.56% | |
| (31.47%) | (26.36%) | (42.07%) | (56.60%) | (84.52%) | (29.73%) | (0.16%) | (70.26%) | (49.40%) | |
ROIC |
0.00% | 60.31% | (57.30%) | (275.79%) | (312.06%) | (127.97%) | 2.47% | 0.00% | 0.00% |
Return on Tangible Assets |
(25,591.67%) | (53.02%) | (122.02%) | (115.39%) | (253.52%) | (120.01%) | (0.77%) | 296.51% | 108.05% |
Average Days of Receivables |
75.21 | 50.79 | 31.66 | 26.27 | 87.34 | 129.12 | 102.39 | 72.87 | — |
Research and Development Expense of Revenue |
22.04% | 17.14% | 22.42% | 25.34% | 32.43% | 11.42% | 1.89% | 24.42% | — |
Selling, General and Administrative Expense of Revenue |
23.84% | 14.34% | 24.94% | 31.64% | 36.38% | 25.69% | 18.20% | 5.32% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.13 | 0.16 | 0.16 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.19% | 5.43% | 1.70% | 1.99% | 2.96% | 2.01% | 2.62% | 0.00% |
Graham Net Nets |
(0.01) | (0.01) | 0.26 | 0.71 | 1.52 | 0.80 | 0.31 | (0.89) | — |
Graham Number |
0.00 | 6,361.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 251.41 | — |
Earnings Yield |
44.37% | 44.37% | (40.46%) | (124.21%) | (441.08%) | (113.07%) | (0.59%) | (227.46%) | — |
Free Cash Flow Yield |
1.26% | 1.26% | (51.83%) | (31.56%) | (439.20%) | (99.50%) | (12.62%) | (58.45%) | — |
Revenue per Share |
29.49 | 71,402.63 | 11,286.50 | 2,489.96 | 1,037.45 | 434.79 | 392.75 | 222.43 | 0.00 |
Operating CF per Share |
(4.45) | 2,032.11 | (3,254.66) | (410.89) | (731.48) | (76.96) | (17.00) | (32.38) | (32.55) |
Capex per Share |
0.00 | (1,339.47) | (131.65) | (0.43) | (0.87) | (0.05) | (0.15) | (0.82) | 0.00 |
Free Cash Flow per Share |
(4.45) | 692.63 | (3,386.31) | (411.32) | (732.36) | (77.01) | (17.15) | (33.19) | (32.55) |
Cash per Share |
0.79 | 6,867.89 | 1,096.89 | 861.52 | 213.56 | 82.27 | 39.42 | 20.39 | 1.80 |
Shareholders Equity per Share |
(4.75) | 2,699.47 | 2,478.16 | 1,105.45 | 354.18 | 124.81 | 93.83 | (21.75) | (11.01) |
Interest Debt per Share |
0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(4.75) | 2,699.47 | 2,478.16 | 1,105.45 | 354.18 | 124.81 | 93.83 | (21.75) | (11.01) |
Free Cash Flow |
(8.91) | 1.32 | (34.88) | (10.57) | (38.52) | (12.37) | (4.09) | (8.70) | (23.53) |
Working Capital |
(0.66) | 15.67 | 19.73 | 25.10 | 14.70 | 11.57 | 11.64 | (11.57) | (19.12) |
Capital Expenditures |
(1.17) | (2.54) | (1.36) | (0.01) | (0.05) | (0.01) | (0.04) | (0.21) | — |
Net Current Asset Value |
(12.39) | 1.65 | 17.41 | 23.67 | 13.23 | 9.99 | 10.11 | (13.27) | (22.94) |
EV/EBIT |
33.73 | 33.73 | 0.00 | 0.00 | 0.06 | 0.04 | 45.02 | 0.00 | — |
Capex to Sales |
0.00 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Net Profit Margin |
(26.01%) | (6.54%) | (22.22%) | (46.77%) | (70.78%) | (20.17%) | (0.10%) | (57.72%) | 0.00% |
Price to Operating Income |
33.06 | 33.06 | 0.00 | 0.00 | 0.00 | 0.00 | 63.16 | 0.37 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
1.82 | 1.73 | 2.44 | 3.24 | 3.99 | 14.14 | 31.07 | 15.67 | 0.00 |
Cash ROIC |
(349.93%) | 8.80% | (74.38%) | (22.40%) | (129.70%) | (37.50%) | (12.98%) | 2,440.62% | 353.67% |
Accounts Receivable Turnover |
3.51 | 8.74 | 8.03 | 8.71 | 6.18 | 3.70 | 3.67 | 3.08 | — |
Accounts Payable Turnover |
2.01 | 4.54 | 4.73 | 6.06 | 5.25 | 3.80 | 3.63 | 4.70 | 0.00 |
Inventory Turnover |
2.51 | 5.68 | 3.95 | 3.16 | 5.70 | 12.31 | 14.25 | 5.65 | — |
Average Days of Payables |
106.04 | 113.76 | 32.30 | 66.26 | 71.80 | 132.48 | 97.49 | 5.57 | 0.00 |
Days of Inventory on Hand |
84.69 | 90.99 | 87.21 | 84.88 | 42.02 | 24.52 | 32.01 | 80.13 | — |
Average Receivables |
16.80 | 15.52 | 14.48 | 7.34 | 8.83 | 18.88 | 25.48 | 18.95 | — |
Average Payables |
19.27 | 19.27 | 17.26 | 8.05 | 9.16 | 15.30 | 20.49 | 10.29 | 2.38 |
Average Inventory |
15.41 | 15.41 | 20.68 | 15.44 | 8.44 | 4.73 | 5.21 | 8.57 | — |
Average Assets |
48.80 | 33.67 | 61.40 | 52.89 | 45.70 | 47.39 | 54.86 | 47.89 | 41.82 |
Average Common Equity |
(42.39) | (42.39) | 15.33 | 26.97 | 23.52 | 19.34 | 21.21 | 8.33 | (6.83) |
Columns are period end dates